Avinger (NASDAQ:AVGR) released its quarterly earnings data on Thursday. The medical device company reported ($0.18) earnings per share for the quarter, beating the consensus estimate of ($0.21) by $0.03, MarketWatch Earnings reports. Avinger had a negative return on equity of 270.15% and a negative net margin of 211.96%.
NASDAQ AVGR opened at $0.45 on Friday. The company has a fifty day simple moving average of $0.37 and a 200 day simple moving average of $0.49. Avinger has a 12-month low of $0.24 and a 12-month high of $2.34. The company has a current ratio of 1.11, a quick ratio of 0.85 and a debt-to-equity ratio of 0.89. The company has a market cap of $13.98 million, a P/E ratio of -0.17 and a beta of 1.31.
AVGR has been the topic of a number of research analyst reports. Zacks Investment Research downgraded shares of Avinger from a “buy” rating to a “hold” rating in a research note on Tuesday, July 14th. LADENBURG THALM/SH SH downgraded shares of Avinger from a “buy” rating to a “neutral” rating in a research note on Monday, April 13th. Finally, Aegis reaffirmed a “buy” rating and set a $1.40 target price on shares of Avinger in a research note on Monday, June 29th.
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Recommended Story: What are the benefits of investing in REITs?
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.